Probe Synthesis and New Compound Characterization.
Preparation of RFAP-0. Synthesis of Compound 2. Compound 2 was prepared through alkyl cuprate addition into compound 1 according to published procedures. 1 Synthesis of compound 3. To a solution of compound 2 (100 mg, 0.23 mmol) in 5 mL of 4:1 MeOH:DCM at 0 °C was added 0.33 mL of NH 3 solution (7 N in MeOH, 2.3 mmol). The reaction mixture was stirred at 0 °C for 30 min, then allylboronic acid pinacol ester (51 μL, 0.27 mmol) was added, and the reaction mixture was warmed to ambient temperature and stirred for 10 h. The solvent was removed under reduced pressure, and purification by silica column chromatography (03% MeOH /DCM) afforded compound 3 as a pale yellow solid (105 mg, 96%). 1 
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Synthesis of RFAP-0. Compound 3 (20 mg, 40 mol) was dissolved in 1.5 mL of 3:1 AcOH:H 2 O, and the reaction mixture was stirred for 10 hours. The reaction mixture was carefully basified with 10% K 2 CO 3 /H 2 O to pH >11, then extracted with DCM (4 x 25 mL). The combined organic layers were washed with brine (1 x 100 mL). The organic layer was dried over anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. Purification by silica column chromatography (gradient from DCM to 10% MeOH/DCM) afforded RFAP-0 as a yellow powder (11 mg, 72% yield). 1 4 (0.65 g, 7.2 mmol). The reaction mixture was stirred under N 2 for 10 h, then diluted with 22 mL CHCl 3 and stirred for an additional 10 minutes. The reaction mixture was filtered through a cotton plug, then 20 mL brine was added. The biphasic mixture was vigorously agitated and the layers were allowed to separate. The organic layer was collected, followed by additional brine washes (2 x 20 mL). The organic layer was dried over Na 2 SO 4 , the volume was measured, and the solution was used directly in further reactions. The yield was assumed to be 50%, 3 resulting in ca. 0.13 M prenylboronic acid solution.
Preparation of RFAP-1. Synthesis of Compound 5. Commercial 7N NH 3 solution (0.33 mL, 2.3 mmol) was added to coumarin aldehyde 2 (100 mg, 230 μmol) dissolved in 5 mL of 4:1 MeOH:DCM and stirred under N 2 for 30 minutes. Freshly prepared (see preparation above) 0.13 M prenylboronic acid solution (2.3 mL, 300 μmol) was added, and a white precipitate immediately formed. After stirring for 1 hour, the reaction mixture became homogeneous. The reaction mixture was stirred for an additional 9 h, and TLC (5% MeOH/DCM) showed complete consumption of starting material. The solvent was removed under reduced pressure. Purification by silica column chromatography (gradient from 1% MeOH/DCM with 0.2% NH 4 OH to 3% MeOH/DCM with 0.2% NH 4 OH) afforded 5 as a yellow powder (110 mg, 95% yield). 1 
Synthesis of RFAP-1.
Compound 5 (53 mg, 100 mol) was dissolved in 4 mL of 3:1 AcOH:H 2 O, and the reaction mixture was stirred for 10 hours. The reaction mixture was carefully basified with 10% K 2 CO 3 /H 2 O to pH >11, then extracted with DCM (4 x 25 mL). The combined organic layers were washed with brine (1 x 100 mL). The organic layer was dried over anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. Purification by silica column chromatography (gradient from 4% MeOH/DCM to 10% MeOH/DCM) afforded RFAP-1 as a yellow powder (28 mg, 68% yield). 1 
Preparation of RFAP-2. Synthesis of Compound 7.
To prepare a solution of the alkylborane coupling partner 6, a round-bottom flask was charged with ethyl 4-pentenoate (0.56 mL, 3.9 mmol) and commercial 0.5 M 9-BBN solution (8.6 mL, 4.3 mmol). The reaction mixture was stirred overnight and used directly for Suzuki coupling.
A 2-neck round-bottom flask was charged with Compound 1 (0.66 g, 2.2 mmol), potassium phosphate tribasic monohydrate (0.81 g, 3.5 mmol), and PEPPSI-IPr catalyst (60 mg, 90 μmol). The atmosphere was replaced with N 2 by 5 evacuation/refill cycles, then a freshly-prepared 0.4 M solution of compound 6 (8.8 mL, 3.5 mmol) was added. The reaction mixture was stirred for 10 h, and TLC (EtOAc) showed complete consumption of starting material. The reaction mixture was diluted with 50 mL EtOAc, run through a plug of silica gel (with EtOAc washes), and concentrated under reduced pressure. Purification by silica column chromatography (gradient from 25% EtOAc/hexanes to 35% EtOAc/hexanes) afforded 7 as an orange oil (0.5 g, 58% yield). 1 Freshly prepared (see preparation above) 0.13 M prenylboronic acid solution (35 mL, 4.6 mmol) was added, and the reaction mixture was stirred for 10 h. The solvent was removed under reduced pressure. The residue was dissolved in 100 mL DCM and washed sequentially with 1% K 2 CO 3 (2 x 100 mL) and brine (1 x 100 mL). The organic layer was dried over anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. Purification by silica column chromatography (gradient from DCM to 3% MeOH/DCM) afforded 8 as a yellow oil (0.66 g, 62% yield). 1 
Synthesis of RFAP-2.
A flame-dried round bottom flask was charged with compound 9 (5 mg, 11.4 μmol), 2-(2-((6-chlorohexyl)oxy)ethoxy)ethan-1-amine (8 mg, 34.2 μmol), and HATU (13 mg, 34.2 μmol), followed by addition of 1 mL dry DMF and triethylamine (10 μL, 57 μmol). The reaction mixture as stirred under N 2 for 8 h. The solvent was removed under reduced pressure. Purification by silica column chromatography (gradient from 6% MeOH/DCM to 8% MeOH/DCM) afforded RFAP-2 as a yellow powder (1.6 mg, 22% yield). 1 
Preparation of RFAP-2-Ald.
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Synthesis of RFAP-2-Ald. RFAP-2 (1 mg, 1.5 μmol) was dissolved in 1 mL 2: Spectroscopic Materials and Methods. Milli-Q water was used to prepare all aqueous solutions. All spectroscopic measurements were performed in 20 mM PBS, pH 7.4. Absorption spectra were recorded using a Varian Cary 50 spectrophotometer, and fluorescence spectra were recorded using a Photon Technology International Quanta Master 4 L-format scan spectrofluorometer equipped with an LPS-220B 75-W xenon lamp and power supply, A-1010B lamp housing with integrated igniter, switchable 814 photocounting/analog photomultiplier detection unit, and MD5020 motor driver. Samples for absorption S6 and emission measurements were contained in 1-cm × 1-cm quartz cuvettes (1.4-mL volume, Starna). All excitation spectra were corrected for the emission profile of the xenon lamp.
Quantum Yield. Quantum yield was determined using coumarin 153 (λ ex = 420 nm) and fluorescein (λ ex = 470 nm) as standards according to a published method. 4 For RFAP-1-Ald, RFAP-1, RFAP-2, coumarin 153, and fluorescein, the absorbance spectra were measured within an absorbance range below 0.1. The quantum yield was calculated according to the equation:
where  is the quantum yield,  coumarin 153 = 0.38 in EtOH, 4  fluorescein = 0.91 in 0.1 M aqueous NaOH, 4 Grad is the slope of the plot of absorbance versus integrated emission intensity, and  is the refractive index of the solvent. was added (for a final concentration of 100 M), and the mixture was mixed by vigorous pipetting for 5 s, followed by acquisition of the t = 0 spectrum. Excitation spectra ( ex = 400-500 nm,  em = 510 nm) were collected at timepoints until saturation was observed. Temperature was maintained at 37 °C throughout the experiment by immersing the cuvette in a heated water bath between measurements. The reaction was assumed to be pseudo-first order under these conditions, and the slope of a best-fit line to the plot of ln((R max -R)/(R max -R 0 )) vs time (where R max indicates saturated excitation ratio, R 0 indicates initial excitation ratio, and R indicates excitation ratio at the current timepoint) was divided by the concentration of FA (100 M) to give the bimolecular rate constant.
RFAP-
Selectivity Tests. 995 L of a 10.05 M solution of RFAP-1 or RFAP-2 (unless otherwise specified) in 20 mM PBS (pH 7.4) was prepared by diluting a 5 mM DMSO stock solution of RFAP-1 or RFAP-2 into prewarmed PBS (37 °C) in a 1-cm × 1-cm quartz cuvette, followed by a 15-minute incubation. The analyte of interest was added to the cuvette to bring the concentration of analyte to 100 M (unless otherwise specified) and the concentration of RFAP-1 or RFAP-2 to 10 M, followed by mixing by vigorous pipetting S7 for 5 seconds, and a t = 0 spectrum was acquired. The cuvette was placed in a 37 °C water bath. Excitation spectra were recorded by quickly removing the cuvette from the water bath, obtaining the spectrum, and returning the cuvette to the bath. Spectra were taken at t = 0, 30, 60, 90, and 120 min. Stock solutions and addition volumes were as follows. Cell Culture Procedures. Cells were maintained by the UC Berkeley Tissue Culture Facility. HEK293T cells were maintained as a monolayer in exponential growth at 37 °C in a 5% CO 2 atmosphere in Dulbecco's Modified Eagle Medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Seradigm), 1% glutamax (Gibco), and 1% non-essential amino acids (NEAA, Gibco). HeLa, RKO, and U-2OS were maintained as a monolayer in exponential growth at 37 °C in a 5% CO 2 atmosphere in DMEM supplemented with 10% FBS and 1% glutamax. MCF-7 and SH-SY5Y cells were maintained as a monolayer in exponential growth at 37 °C in a 5% CO 2 atmosphere in DMEM supplemented with 10% FBS, 1% glutamax, 1% NEAA, and sodium pyruvate. MCF-10A were maintained as a monolayer in exponential growth at 37 °C in a 5% CO 2 atmosphere in DMEM/F-12 supplemented with 5% horse serum (Hyclone), 10 mM HEPES, 0.5 mg/mL hydrocortizone, 100 ng/mL cholera toxin, 20 ng/mL EGF, 10 g/ml insulin. ADH5 -/-and genetically matched WT HAP1 cells were maintained in exponential growth at 37 °C in a 5% CO 2 atmosphere as a monolayer in Iscove's Modified Dulbecco's Medium, high glucose, (IMDM, Invitrogen) supplemented with 10% FBS. One day before imaging, HEK293T, MCF-7, SH-SY5Y, HAP1 ADH5 -/-, and HAP1 WT cells were passaged and plated on poly-L-lysine-coated 4-well Lab Tek borosilicate chambered coverglass slides (Nunc) at 1.8 × 105 per well and allowed to grow to between 70 and 80% confluence before imaging. One day before imaging, HeLa, MCF-10A, RKO, and U-2OS cells were passaged and plated on 4-well Lab Tek borosilicate chambered coverglass slides and allowed to grow to between 70 and 80% confluence before imaging.
Confocal Fluorescence Imaging Experiments.
Confocal fluorescence imaging studies were performed with a Zeiss laser scanning microscope 710 with a 20x or 63x oil immersion objective lens using Zen 2009 software (Carl Zeiss). RFAP-1 and RFAP-2 were excited using 405 nm diode laser and 488 nm argon laser, and emission was collected using a META detector between 410 to 550 nm (405 nm excitation) and 493 to 550 nm (488 nm excitation). BSS (136.9 mM NaCl, 5.37 mM KCl, 1.26 mM CaCl 2 , 0.81 mM MgSO 4 , 0.44 mM KH 2 PO 4 , 0.335 mM Na 2 HPO 4 , 10 mM PIPES; pH to 7.2 with NaOH) was used as the imaging buffer for all confocal experiments. The cells were imaged at 37 °C throughout the course of the experiment. Image analysis and quantification was performed using ImageJ (National Institutes of Health). For quantification of excitation ratio, three fields of cells within the same well were imaged. A region of interest (ROI) was S9 created around each cell in each image. The mean fluorescence intensity of each cell was measured (using "Measure" function) for each excitation wavelength and averaged across the three fields imaged. For each condition, multiple wells were analyzed using this process, and the 488/405 excitation ratios were averaged across independent experiments for statistical analysis. Statistical analyses for multiple comparisons were performed using one-way ANOVA with the Bonferroni correction in the statistical analysis software, R.
Exogenous FA Addition Experiments in Various Cell Types. One day before imaging, HEK293T, MCF-7, and SH-SY5Y cells were passaged and plated on poly-L-lysine-coated 4-well Lab Tek borosilicate chambered coverglass slides and allowed to grow to between 70 and 80% confluence before imaging. One day before imaging, HeLa, MCF-10A, RKO, and U-2OS cells were passaged and plated on 4-well Lab Tek borosilicate chambered coverglass slides and allowed to grow to between 70 and 80% confluence before imaging. The DMEM media was aspirated from the chambers containing cells and replaced with 500 L DMEM (supplemented with 10% FBS and glutamax) containing 10 M RFAP-1 or RFAP-2 (diluted from 5 mM stock in DMSO) and incubated at 37 °C for 30 minutes. The buffer was then replaced with 500 L fresh DMEM (supplemented with 10% FBS and glutamax) containing no probe, and the cells were incubated at 37 °C for 10 minutes to remove any excess probe. The buffer was then replaced with 500 L BSS, and cells were imaged to provide the t = 0 timepoint. 200 L of the buffer was removed from each well and mixed with vehicle control ( 
HAP1 ADH5 -/-and WT Confocal Imaging and Flow Cytometry Experiments.
Confocal Imaging Experiments. One day before imaging, ADH5-/-and WT HAP1 cells were passaged and plated on poly-L-lysine-coated 4-well Lab Tek borosilicate chambered coverglass slides and allowed to grow to between 70 and 80% confluence before imaging. The media was aspirated from the chambers containing cells and replaced with 500 L BSS containing 500 nM RFAP-2 (diluted from 500 M stock in DMSO) and incubated at 37 °C for 30 minutes. The buffer was then replaced with 500 L BSS supplemented with either vehicle control (5 L H 2 O) or 100 M FA (5 L of a 10.1 mM FA stock). The cells were then incubated at 37 °C for 60 min prior to imaging for the t = 60 timepoint.
Flow Cytometry Experiments. One day before imaging, ADH5 -/-and WT HAP1 cells were passaged and plated on 12-well polystyrene culture plates (Corning) and allowed to grow to 80% confluence. The media was aspirated from the wells containing cells and replaced with 500 L BSS containing 500 nM RFAP-2 (diluted from 500 M stock in DMSO) and incubated at 37 °C for 30 minutes. Figure S1 . Linearized integrated rate law of reaction between 100 M FA and 10 M RFAP-0 (red triangles) or RFAP-1 (blue squares) assuming pseudo-first order kinetics. . Flow cytometric analysis of ADH5 -/-and WT cell viability using Sytox Red staining. Cells were plated in 12-well polystyrene culture plates (Corning). After the designated treatments below, cells were dislodged from wells by gentle agitation and filtered through 35 μm nylon mesh cap into a 12 x 75 mm polystyrene tube (Corning) for flow cytometry. Cell viability was calculated as the percentage of Sytox Red-negative cells. ADH5 -/-and WT HAP1 cells were incubated with 500 nM RFAP-1 in BSS at 37 °C for 30 min, then exchanged into BSS containing either vehicle control or 100 M FA and incubated at 37 °C for a further 60 min. Cells were then exchanged into PBS containing 5 nM Sytox Red and incubated for 10 min before flow cytometry. Error bars denote SEM, n=3.
